Application of coracoid approach brachial plexus nerve block combined with posterior suprascapular nerve block in arthroscopic shoulder surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100043069

Enrollment

Unknown

Registered

2021-02-04

Start date

2021-02-07

Completion date

Unknown

Last updated

2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arthroscopic shoulder surgery

Interventions

Group A:supraclavicular brachial plexus block

Group B:coracoid approach brachial plexus combined with posterior approach suprascapular nerve block

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients undergoing arthroscopic surgery of the right shoulder, aged 18-60 years, BMI 18-28kg/m2, ASA I-II grade.

Exclusion criteria

Exclusion criteria: Previous local anesthetic allergy, severe systemic infection or puncture site infection, coagulation dysfunction, neuromuscular disease, lung disease or long-term smoking without quitting.

Design outcomes

Primary

Measure	Time frame
the rate of hemidiaphragmatic paralysis;	—

Secondary

Measure	Time frame
VAS;Sufentanil consumption;	—

Countries

China

Contacts

Public ContactHe Wensheng

The First Hospital of Qinhuangdao

hws2008hws@163.com+86 1503352612

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026